[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100493125":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":30,"responsibleParty":46,"collaborators":19,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":19,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":19,"enrollmentInfo":57,"targetDuration":19,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":66,"overallStatus":32,"whyStopped":19,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Case Comprehensive Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"PRE-ACT Adaptation","EXPERIMENTAL","At the scheduled oncologic visit: consent obtained and all participants will complete the Demographics\u002FClinical Characteristics survey and Pre-Intervention Survey\n\nWithin 3 months of consent: tailored educational intervention and patient navigation program will take place and the scored Pre-Intervention survey will be used to generate a list of barrier for each patient. The patient will be asked to view educational videos on an iPad that correspond with each identified barrier. Afterwards, the patient navigator will lead a discussion based on the topics discussed.\n\nWithin 4 weeks of the educational video: the participant will be contacted via phone to complete a Post-Intervention Survey that assesses knowledge, attitudes, and preparation related to participation in clinical trials\n\nTwo years after intervention: chart review will be performed to assess if the patient participated in a clinical trial.",[13],"Other: Educational Intervention",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Educational Intervention","The intervention will occur at a separate dedicated in-person visit with the patient navigator estimated to last 30-45 minutes. The Pre-Intervention Survey will be scored to generate a list of barriers identified for each patient. This list of barriers will be reviewed by the patient navigator prior to the intervention date. The patient will be asked to view educational videos on an iPad that correspond with each identified barrier. Afterwards, the patient navigator will lead a discussion based on the topics discussed.",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Lauren Chiec, MD","University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center","PRINCIPAL_INVESTIGATOR",[26],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},"CONTACT","216-286-6741","lauren.chiec@uhhospitals.org",[31],{"facility":23,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Cleveland","Ohio","44106","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-81.69541,41.4995,{"lat":42,"lon":41},[45],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},{"type":47,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100493125","patient-navigator-pre-act-educational-intervention-to-promote-decision-making-among-minorities-100493125",false,"NCT05701085","Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities","Prospective Cohort Study of a Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making About Clinical Trials Among Racial and Ethnic Minorities","Inclusion Criteria:\n\n* Participants must have a diagnosis of either advanced (metastatic) cancer or early stage disease for which they are undergoing oncological work-up, treatment or surveillance\n* Participants must be at least 18 years of age\n* Participants have a non-white race or Hispanic ethnicity recorded in their patient demographics in the electronic medical record\n* Participant must have a life expectancy greater than three months based on the primary oncology team's clinical assessment.\n* Participants must be able to read and verbally communicate in English.\n* Participants must provide written informed consent.\n\nExclusion Criteria:\n\n\\-","ALL","18 Years",{"count":58,"type":59},240,"ESTIMATED","INTERVENTIONAL",[62],"NA","This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study and will be combined with a patient navigator model.",[16,65],"Minorities",[67],"PRE-ACT","2026-04-03",{"date":70,"type":71},"2026-04-07","ACTUAL",{"date":73,"type":71},"2023-04-24",{"date":75,"type":59},"2026-12-30",{"name":5,"class":6},1]